Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. News/
  3. Innovation/
  4. Award criteria
speaker

Award criteria

About the award:

The Scholars Award is a three-year award in the gross amount of $150,000, which will be paid to the University (the “Recipient”) for the benefit of the Johnson & Johnson Scholar and her research, with the understanding that the Recipient will administer the funds. The Scholars Award will be paid in three (3) installments of U.S. $50,000 per year of the three-year scholarship period, payable in 2022, subject to compliance with the terms and conditions of the program’s Agreement. Winners achievements will also be showcased at a symposium.

The following award criteria applies:

Standards for evaluation:

Judges will use the following criteria to evaluate the applications:

  • Scientific/technical expertise exhibited
  • Novelty/innovation of the research
  • Potential impact of the research
  • Feasibility of the research

You must be a woman working in the field(s) of Science, Technology, Engineering, Mathematics, Manufacturing and Design (STEM2D).

You must be an early to mid-career women working within a STEM2D university department at the time of application at an accredited academic university, institution or design school. Examples include a non-tenured assistant professor, assistant professor or associate professor.

The female scholar should have a minimum degree for the appropriate field:

  • Science; M.D., Ph.D.
  • Technology; Ph.D.
  • Engineering; Ph.D.
  • Math; M.S., Ph.D.
  • Manufacturing; Ph.D.
  • Design; M.A., M.S., MDes, MArch, MFA, MLA, Ph.D.

WiSTEM2D Scholars Award

The Johnson & Johnson WiSTEM²D Scholars Award Program will help develop female leaders and support innovation in STEM fields.

More from Johnson & Johnson

Getting in front of cancer

Every year, roughly 2 million people in the U.S. are newly diagnosed with cancer. But new scientific breakthroughs—including ones made at Johnson & Johnson—have dramatically changed the prognosis of many of these patients.

6 things to know now about colorectal cancer

Colorectal cancer is now the leading cause of U.S. cancer deaths among people under 50, and rates of the disease are rising globally, too. For Colorectal Cancer Awareness Month, find out how to protect yourself—no matter your age.

“My company makes the medication that helped me fight multiple myeloma”

Paul Reidy, a Johnson & Johnson warehouse technician in Ireland, never imagined that an oncology therapy made at the facility where he works would help save his life.